source
- Scribe Therapeutics files for Nasdaq IPO, testing market appetite for early-stage gene-editing firmsScribe Therapeutics announced it has filed a registration statement to list its shares on the Nasdaq, marking the company’s first step toward a public offering. The filing highlights the growing i…
- Medicare proposes 33% cut to 340B drug payments for hospitalsMedicare has released a proposal to cut payments to hospitals for drugs bought through the 340B discount program by more than a third. Under the plan, Medicare would reimburse hospitals at the aver…